KERYX BIOPHARMACEUTICALS INC 4 SEC Filings

Filed On	Filing
13 Dec 2018	Form 4: Rogers Michael W, Director Returned 30,000 shares to the issuer · Disposed of 140,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Enyedy Mark J, Director Returned 10,000 shares to the issuer · Disposed of 80,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Holmes Scott A, Chief Financial Officer Returned 162,956 shares to the issuer · Disposed of 902,500 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Morrison Jodie Pope, Director Returned 120,000 shares to the issuer · Disposed of 110,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Regan Daniel Paul, Director Returned 60,000 shares to the issuer · Disposed of 200,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Heffernan Michael Thomas, Director Returned 20,000 shares to the issuer · Disposed of 110,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Gilman Steven C, Director Returned 27,333 shares to the issuer · Disposed of 140,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Neylan John F., Chief Medical Officer Returned 148,279 shares to the issuer · Disposed of 772,500 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Cameron Kevin J, Director Returned 186,666 shares to the issuer · Disposed of 290,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Carberry Christine A., Chief Operating Officer Sold 10,469 shares ($33.7K) · Returned 100,646 shares to the issuer · Disposed of 422,500 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Baupost Group LLC/MA, Director and 2 others Received 39,582,335 shares as a grant or award · Exercised 0 Zero Coupon Senior Convertible Notes due 2021 · Returned 65,374,013 shares to the issuer
16 Nov 2018	Form 4: Neylan John F., Chief Medical Officer Sold 1,156 shares ($3.2K)
16 Nov 2018	Form 4: Holmes Scott A, Chief Financial Officer Sold 1,155 shares ($3.2K)
30 Oct 2018	Form 4: Neylan John F., Chief Medical Officer Sold 1,253 shares ($3.85K)
30 Oct 2018	Form 4: Holmes Scott A, Chief Financial Officer Sold 1,254 shares ($3.85K)
22 Oct 2018	Form 4: Carberry Christine A., Chief Operating Officer Sold 2,040 shares ($6.71K)
16 Aug 2018	Form 4: Holmes Scott A, Chief Financial Officer Sold 1,185 shares ($3.6K)
16 Aug 2018	Form 4: Neylan John F., Chief Medical Officer Sold 1,186 shares ($3.61K)
31 Jul 2018	Form 4: Neylan John F., Chief Medical Officer Sold 1,282 shares ($4.95K)
31 Jul 2018	Form 4: Holmes Scott A, Chief Financial Officer Sold 2,354 shares ($9.09K)

Comments